tiprankstipranks
Trending News
More News >
Lipella Pharmaceuticals, Inc. (LIPO)
OTHER OTC:LIPO
US Market

Lipella Pharmaceuticals, Inc. (LIPO) Income Statement

Compare
109 Followers

Lipella Pharmaceuticals, Inc. Income Statement

Last quarter (Q3 2025), Lipella Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Lipella Pharmaceuticals, Inc.'s net income was $-1.25B. See Lipella Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 536.36K$ 449.62K$ 184.16K$ 259.35K$ 961.68K
Gross Profit
$ -3.08M$ -2.59M$ -2.36M$ -1.20M$ -14.28K
Operating Expenses
$ 2.00M$ 2.16M$ 226.19K$ 718.38K$ 42.59K
Depreciation and Amortization
$ 2.89K$ 1.69K$ 0.00$ 0.00$ 0.00
EBITDA
$ -5.01M$ -4.61M$ -2.59M$ -1.86M$ -53.69K
Operating Income
$ -5.08M$ -4.75M$ -2.59M$ -1.92M$ -56.86K
Other Income/Expenses
$ 64.28K$ 126.99K$ -7.98K$ 50.35K$ -4.79K
Pretax Income
$ -5.02M$ -4.62M$ -2.60M$ -1.87M$ -61.66K
Net Income
$ -5.02M$ -4.62M$ -2.60M$ -1.87M$ -61.66K
Per Share Metrics
Basic EPS
$ -4.79$ -6.16$ -5.12$ -4.00$ -0.23
Diluted EPS
$ -4.79$ -6.16$ -5.12$ -4.38$ -0.23
Weighted Average Shares Outstanding
1.05M 749.83K 507.36K 466.48K 266.40K
Weighted Average Shares Outstanding (Diluted)
1.05M 750.38K 507.58K 426.01K 266.40K
Currency in USD

Lipella Pharmaceuticals, Inc. Earnings and Revenue History